DK Medical Technology Co. Ltd., a Suzhou-based developer of vascular intervention balloon products, has reportedly secured “hundreds of millions” of renminbi in a Series E financing round. The round was co-led by Legend Capital and Qiming Venture Partners, with additional investments from existing shareholders. The funds will be utilized to expand manufacturing capabilities and commercialization efforts.
Established in 2015, DK Medtech has a product portfolio of over 10 types of balloons, including standard balloons, high-pressure balloons, scored balloons, and drug-eluting balloons, catering to cardiovascular intervention, peripheral intervention, and neurological intervention segments. The company has obtained 13 Class III medical device certifications, with its coronary scoring balloon dilation catheter, scoring balloon dilation catheter, and peripheral scoring drug balloon dilation catheter being the first of their kind to gain marketing approval in China.- Flcube.com
